A Double-blind Placebo Controlled Study of Mixed-amphetamine Salts, Extended Release (Adderall XR) for Cognitive Impairment in MS
Phase of Trial: Phase II/III
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Mixed amfetamine salts (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 28 Dec 2016 Status changed from not yet recruiting to recruiting.
- 27 May 2016 Planned initiation date changed from 1 May 2016 to 1 Jun 2016.
- 15 Apr 2016 Planned initiation date changed from 1 Apr 2016 to 1 May 2016.